Physicians’ Opinions Survey on FDA’s Bydureon Approval

Report Description

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Infection Prevention and Control Market 2014-2018

Infection prevention and control is the most important and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals, and Food industries. Sterilization and disinfection protect different products and materials from decaying or being spoiled by microbes. Sterilization and disinfection can be performed by using various products and types of equipment. The market is experiencing growth through the increased adoption of contract sterilization and in-house sterilization procedures by hospitals and various industries. TechNavio's analysts forecast the Global Infection Prevention and Control market will grow at a CAGR of 7.47 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth pros......
$3000

Global Parkinson’s Disease Market 2014-2018

Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent leads to the development of symptoms associated with Parkinson's disease such as tremor, bradykinesia, and muscular rigidity. It is usually diagnosed in the population aged 60 and over; however, earlier incidences have been reported. Based on the severity, it can be categorized into early stage, mid stage and late (or advanced) stage. Currently, the approved therapies provide only symptomatic relief. Levodopa is the standard drug for the treatment of Parkinson's disease; however, it is associated with the incidenc......
$2500

Global Retinal Vein Occlusion Market 2014-2018

Retinal vein occlusion is a medical condition where there is a blockage in the retinal veins. This blocks the flow of blood in the retina, which can damage the nerve cells of the eye and result in loss of vision. Retinal vein occlusion can occur as a result of a clot in a vein, especially if the veins of the eye are very narrow. The disease is likely to affect people who are already suffering from hypertension, diabetes mellitus, or hyperlipidaemia. Retinal vein occlusion is one of the most common causes of blindness after diabetic retinopathy. It is also one of the most common vascular disorders of the eye. Retinal vein occlusion can be broadly classified into two types, central retinal vein occlusion and branch retinal vein occlusion, with the latter being more frequent. Central retinal ......
$2500

Global Nicotine Gum Market 2014-2018

Nicotine gum is a smoking cessation product that helps smokers to slowly overcome nicotine addiction. Nicotine is released by chewing the gum and is absorbed into the blood stream through the lining of the mouth, which helps smokers to slowly reduce their craving for nicotine. Nicotine gum helps the human body battle the strong urge for nicotine after reducing the number of cigarettes smoked. The gum is available in various dosages and can be consumed according to the level of addiction. TechNavio's analysts forecast the Global Nicotine Gum market will grow at a CAGR of 4.46 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Nicotine Gum market for the period 2014-2018. To calculate market size, ......
$2500

Global Nicotine Patch Market 2014-2018

A nicotine patch is a smoking cessation product that helps the smokers to slowly reduce their addiction to nicotine. The patch is worn on the skin. It releases stream of nicotine into the blood through the skin. This helps reduce the physical withdrawal symptoms that occur during the initial period of quitting smoking. It provides a continual level of nicotine throughout the day. The patches help the human body battle the strong urges for nicotine after reducing the number of cigarettes smoked. Patches are available in various dosages and they can be applied according to the level of addiction. TechNavio's analysts forecast the Global Nicotine Patch market will grow at a CAGR of 18.05 percent over the period 2013-2018. Covered in this Report This report covers the present scenario......
$2500

Global Rheumatoid Arthritis Drugs Market 2014-2018

RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs. The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA. TechNavio's analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018. Covered in this Report ......
$2500

Global Particle Size Analysis Market 2014-2018

Particle size analysis is a technique used to determine the size of a particle in a material such as powder or liquid. It is crucial to analyze the size of particles as it can affect the functionality of the material. Therefore, particle size analysis is performed to determine the behavior and nature of a material, and for its effective functioning (performance and stability). Particle size analysis is used in numerous industries such as Healthcare, Chemical, Mining, and Agriculture. TechNavio's analysts forecast the Global Particle Size Analysis market will grow at a CAGR of 5.01 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Particle Size Analysis market for the period 2014-2018. To calcula......
$2500

Global Hormone Replacement Therapy Market 2014-2018

Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually initiated at menopause or may be started while a woman is in the perimenopausal phase, nearing menopause. Hormone replacement therapy replenishes the hormones required by the human body to function by using bio-identical hormones. The therapy contains estrogen and progesterone, and in some cases testosterone, to reduce symptoms of menopause. This replacement therapy may also protect against osteoporosis, reduce the risk of coronary heart disease, and may prevent or delay the onset of Alzheimer's disease. Replacement therapy can also increase the chance of developing more serious health complications such as blood clots, ......
$2500

Global Macular Edema Market 2014-2018

Macular edema results from fluid accumulation in the macular region of the retina. Macular edema arises from various etiologies such as diabetes, AMD, and RVO. Macular edema disrupts the central vision due to swelling of the macula. Currently, the treatment plan involves the use of surgical and laser therapies as well as drugs such as anti-VEGF therapies and NSAIDs. Surgery and laser therapy are intended to prevent further damage to vision. However, anti-VEGF therapies have been reported to improve the vision loss associated with macular edema. TechNavio's analysts forecast the Global Macular Edema market will grow at a CAGR of 9.1 percent over the period 2014-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Macular Edema ......
$2500

Global Women’s Health Market 2014-2018

Women experience physiological and emotional issues during different phases of their life cycle due to hormonal changes. Women's health is especially referred to where reproductive health is involved. According to the Society for Women's Health Research in the US, issues specific to the human female anatomy are defined as women's health. The biological mechanisms influence the clinical course of diseases and disorders differently in women when compared to men. Some of the main women's health disorders include infertility, menopause, endometriosis and polycystic ovarian syndrome as well as urological disorders and cancers such as breast cancer, cervical cancer, endometrial cancer, and ovarian cancer. In addition, contraception plays an important role in women's health for many reasons, so t......
$2500